According to the relevant announcement, in her new role, Elena will be responsible for the strategy, planning and implementation of AstraZeneca Greece & Cyprus’ institutional relations, corporate communication and the further strengthening of the company’s reputation. At the same time, she will be responsible for internal communication, contributing to the shaping of an excellent working environment based on collaboration, inclusion and the shared commitment of AstraZeneca’s people.
Stavros Ntogiakos, President and CEO of AstraZeneca Greece & Cyprus, stated: “We welcome Elena Armelidou to AstraZeneca Greece & Cyprus. Her deep knowledge in the fields of Public Affairs and Health Policy, her experience in developing solutions that enhance patients’ access to innovative therapies, and her strategic approach will contribute significantly to the further strengthening of AstraZeneca’s presence and voice in the dialogue on health.
At AstraZeneca, we remain committed to collaboration, meaningful dialogue and creating value for patients and the healthcare system.
I am confident that Elena will work effectively with our colleagues and with all stakeholders in the healthcare system, contributing to the advancement of our priorities and to improving the timely access of patients to innovative therapies they need within a sustainable healthcare ecosystem.
We would also like to warmly thank Giota Kotsekidou for her valuable contribution to AstraZeneca over the past 13 years. With consistency, professionalism and dedication, she made a substantial contribution to the company’s progress from various positions of responsibility.
In recent years, her contribution has been instrumental in strengthening the company’s reputation and shaping meaningful collaborations and initiatives, with a positive impact on the sustainability of the Healthcare System.
At the same time, she played a decisive role in creating a motivated, dynamic and capable Corporate Affairs team, with a strong spirit of collaboration and a focus on achieving results. We thank her and wish her every success in the new chapter of her life.”
On the occasion of assuming her new duties, Elena Armelidou stated: “It is a great joy and honor for me to join the AstraZeneca Greece & Cyprus family, a company that leads in biopharmaceutical innovation worldwide.
At the same time, it is a significant responsibility for me to succeed Giota Kotsekidou, recognizing her important work, her capable team and her valuable legacy. At a time of challenges but also great opportunities for health, meaningful dialogue with all institutional stakeholders is a priority.
I am committed to continuing this successful course, working to create strategic partnerships that bridge scientific progress with society and ensure that patients will have immediate and equitable access to the innovative therapies they need, within a sustainable and resilient healthcare system.”